TG Therapeutics Inc.

TGTX | NASDAQ

Price Alert Chart Builder DCF Calculator

$57.16

+$0.29 (+0.51%)

At close: Sep 21, 2026, 4:00 PM ET

$57.30

+$0.14 (+0.24%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Revenue	616.29M	329M	233.66M	2.79M	6.69M	152K
Cost of Revenue	100.71M	38.49M	14.13M	265K	790K	n/a
Gross Profit	515.57M	290.52M	219.53M	2.52M	5.9M	152K
Operating Income	123.32M	41.93M	20.63M	-218.32M	-344.77M	-273.59M
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	107.39M	25.59M	13.06M	-223.81M	-348.1M	-279.38M
Net Income	447.18M	23.38M	12.67M	-223.81M	-348.1M	-279.38M
Selling & General & Admin	232.03M	154.3M	122.71M	95.48M	128.09M	107.85M
Research & Development	160.22M	94.29M	76.19M	125.35M	222.58M	165.9M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	392.25M	248.59M	198.9M	220.84M	350.67M	273.75M
Interest Expense	26.73M	24.03M	12.62M	10.19M	5.64M	6.33M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	492.96M	287.08M	213.03M	221.1M	351.46M	273.75M
Income Tax Expense	-339.79M	2.21M	390K	n/a	n/a	n/a
Shares Outstanding (Basic)	144.32M	145.32M	141.96M	135.41M	132.22M	115.33M
Shares Outstanding (Diluted)	161.41M	160.34M	148.51M	135.41M	132.22M	115.33M
EPS (Basic)	3.10	0.16	0.09	-1.46	-2.63	-2.42
EPS (Diluted)	2.77	0.15	0.09	-1.46	-2.63	-2.42
EBITDA	134.36M	49.9M	26.1M	-213.11M	-341.97M	-272.68M
EBIT	134.12M	49.62M	25.68M	-213.62M	-342.46M	-273.05M
Depreciation & Amortization	244K	280K	423K	515K	494K	374K